CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Evaluation of Hepatic Uptake of OATP1B Substrates by Short Term-Cultured Plated Human Hepatocytes: Comparison With Isolated Suspended Hepatocytes - Journal of Pharmaceutical Sciences

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy

Brain organoid: a 3D technology for investigating cellular composition and interactions in human neurological development and disease models in vitro, Stem Cell Research & Therapy

Using CRISPR/Cas9 to model human liver disease - ScienceDirect

PDF) Human and Mouse Artificial Chromosome Technologies for Studies of Pharmacokinetics and Toxicokinetics

Clinical trials and promising preclinical applications of CRISPR/Cas gene editing - ScienceDirect

Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy - Cytotherapy

Chemical Biology and its relations to Metabolic Disease, Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development

Medicina, Free Full-Text

Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance

Advances in organ-on-a-chip engineering